Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SA4Ag Vaccine in Japanese Adults
NCT02492958Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2015
- Primary completion
- Sep 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Staphylococcus aureus 4-antigen vaccine in staphylococcal infection, sponsored by Pfizer. Started Jun 2015; status: completed.
02
Drugs
Staphylococcus aureus 4-antigen vaccine
03
Conditions
staphylococcal infection
Beyond the preview
Go deeper on NCT02492958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492958.